StockLens
Home
Portfolio
Trading Decision
Links
Notes
Alerts
Idea
Search
Search
New Stock Screener
/ filters
RSI
any
oversold (<30)
30–40
30–50
40–50
40–55
50–60
60–70
overbought (>70)
MACD
any
positive
negative
near zero (±0.05)
MACD Signal
any
positive
negative
above MACD
below MACD
Histogram
any
positive & growing
positive & shrinking
near zero (±0.02)
negative & shrinking
negative & growing
52 Week Range
any
above 100%
100 - 75%
75 - 50%
50 - 20%
below 20%
Volume
any
above 20-day avg
volume spike 1.5* 20da
below 20-day avg
above 50-day avg
below 50-day avg
above 200-day avg
below 200-day avg
above 20-day / below 50-day
above 50-day / below 200-day
above 20-day and 50-day avg
below all averages (20/50/200)
Sector
any
basic materials
communication services
consumer cyclical
consumer defensive
energy
financial services
healthcare
industrials
real estate
technology
utilities
Recommendation Key
any
buy
hold
sell
strong buy
underperform
Market Cap
any
nano cap (< 50M)
micro cap (50M - 300M)
small cap (300M - 2B)
mid cap (2B - 10B)
large cap (10B - 200B)
mega cap (> 200B)
Relative Strength
any
above 100%
100 - 75%
75 - 50%
50 - 20%
below 20%
%B (Percent B)
any
below lower band (<0)
above lower band (>0)
lower zone (0–0.2)
mid zone (0.2–0.8)
upper zone (0.8–1.0)
above upper band (>1)
Price to Book
any
below 1.0
below 1.5 (value)
below 2.0
below 3.0
1.0 – 1.5
1.5 – 3.0
above 3.0
Trailing PE
any
below 10
below 15
below 20 (value)
velow 25
0 – 10
10 – 20
20 – 30
above 30
Return on Equity
any
above 5%
above 10%
above 12% (strong)
above 15%
above 20%
5% – 12%
12% – 20%
below 5%
Debt To Equity
any
below 0.25 (very low)
below 0.5 (low)
below 1.0 (moderate)
below 1.5
below 2.0
0.5 – 1.0
1.0 – 2.0
above 2.0 (high)
Other
any
price above 50 & 200-day MA (uptrend)
dividend yield above 3%
dividend yield > 1% and dividend growing (5y)
earnings report within 14 days
EPS growth positive in each of last 4-5 years
net cash positive (cash > total debt)
free cash flow yield above 5%
EPS turned positive vs prior year (turnaround)
Exluding Finance and BioTech
undervalued mean reversion – 2y
reversal strategy
Earnings/Revenue Gro
any
above 0% (growing)
above 5%
above 10% (good)
above 20% (strong)
above 30% (high growth)
0% – 10%
10% – 20%
20% – 30%
Below 0% (declining)
Predefined Filters
any
1.Liquid large-cap momentum
2.Breakout scan
3.Oversold quality stocks
4.Dividend-income screen
5.Value / quality screen
6.Catalyst scan
7.Liquid, profitable small-cap uptrend
8.Steady compounder
9.Cash-rich growth
10.Undervalued cash-flow machine
11.Profitable turnaround
12.Quality momentum
13.Low-debt dividend grower
14.Breakout with fundamentals
Portfolio
all portfolios
AAII
IJR - Core S&P Small-Cap
VOO - S&P 500
IWM - iShares Russell 2000
IWR - iShares Russell Mid-Cap
IJH - 400 Mid cap
Name
Test1
Ani
Joie
AAII
Ex-AAII
NEW AAII Inv on Indicators
Watch List
Sector
RND_10_7_2026
ET
Google_BUY_Rating
Reversal Strategy
Order
any
date
ticker
price
volume
avg volume 20
latest rsi
prev rsi
%b
bandwidth
macd
macd signal
histogram
prev histogram
relative strength
52 week range
By
any
des
asc
Search
Charts
Reset
Download
5 result(s) found
results — 5 row(s)
Score
Ticker
Name
Price
52 Week Range
Change%(w,m,q,y)
Recom
%B
RSI
Hist
RS
MACD/S
41
BBW
Build-A-Bear Workshop, In
$24.39
4.4
/
-64.9%
23.4/69.5
6.5
/
6.7
/
27.0
/
55.0
strong buy
0.19
41.1↑
0.08
0.41
0.99
/
1.07
Price
Volume
Momentum
Market Cap
Financial Strength
Growth/Profitability
SMA 20
$25.23
3.33%
Current
0.38M
Bandwidth
10.800
Market Cap
307
Trailing P/E
5.93
Revenue Growth
-0.07
SMA 50
$28.68
14.95%
SMA 20
0.34M
12.92%
Lower
$23.86
Ent Value
413
Forward P/E
6.32
Earnings Growth
-0.26
SMA 200
$37.97
35.76%
SMA 50
0.65M
41.36%
Upper
$26.59
Cash
14
PEG Ratio
0.43
Gross Margin
0.55
SMA 200
0.45M
-14.84%
Debt
126
Price/Sales
0.59
Operating Margin
0.10
Free CF
7
Debt/Equity
78.94
Return on Assets
0.10
RS
3M : -0.27
6M : -0.34
9M : -0.61
12M : -0.55
Current Ratio
1.60
Return on Equity
0.33
📝
📈
Finviz
Trading View
Yahoo
Google
Chat GPT
Quick Ratio
0.39
Beta
1.01
37
CAR
Avis Budget Group, Inc.
$101.55
15.8
/
-85.8%
87.7/714.0
7.5
/
5.7
/
36.3
/
34.6
hold
0.16
37.7↑
0.30
0.37
5.28
/
5.57
Price
Volume
Momentum
Market Cap
Financial Strength
Growth/Profitability
SMA 20
$106.38
4.54%
Current
0.34M
Bandwidth
13.510
Market Cap
3,633
Trailing P/E
N/A
Revenue Growth
-0.01
SMA 50
$121.33
16.30%
SMA 20
0.4M
14.81%
Lower
$99.20
Ent Value
32,361
Forward P/E
19.28
Earnings Growth
8.80
SMA 200
$154.33
34.20%
SMA 50
0.39M
11.87%
Upper
$113.57
Cash
558
PEG Ratio
0.17
Gross Margin
0.27
SMA 200
1.26M
-72.62%
Debt
29,125
Price/Sales
0.31
Operating Margin
0.15
Free CF
1,093
Debt/Equity
N/A
Return on Assets
0.03
RS
3M : -0.36
6M : -0.56
9M : -0.19
12M : -0.35
Current Ratio
0.85
Return on Equity
N/A
📝
📈
Finviz
Trading View
Yahoo
Google
Chat GPT
Quick Ratio
0.67
Beta
2.11
64
LENZ
LENZ Therapeutics, Inc.
$3.25
1.9
/
-89.8%
3.2/32.0
9.0
/
21.3
/
40.7
/
89.6
buy
0.17
33.9↑
0.01
0.64
0.30
/
0.30
Price
Volume
Momentum
Market Cap
Financial Strength
Growth/Profitability
SMA 20
$3.57
8.96%
Current
0.94M
Bandwidth
27.190
Market Cap
103
Trailing P/E
N/A
Revenue Growth
0.10
SMA 50
$4.25
23.60%
SMA 20
0.77M
21.98%
Lower
$3.08
Ent Value
-117
Forward P/E
-1.12
Earnings Growth
N/A
SMA 200
$8.41
61.35%
SMA 50
0.73M
27.83%
Upper
$4.05
Cash
220
PEG Ratio
N/A
Gross Margin
0.92
SMA 200
0.91M
+3.70%
Debt
1
Price/Sales
4.78
Operating Margin
-6.23
Free CF
-71
Debt/Equity
0.26
Return on Assets
-0.37
RS
3M : -0.41
6M : -0.64
9M : -0.85
12M : -0.90
Current Ratio
13.55
Return on Equity
-0.59
📝
📈
Finviz
Trading View
Yahoo
Google
Chat GPT
Quick Ratio
12.91
Beta
1.73
25
MPAA
Motorcar Parts of America
$10.14
6.5
/
-42.8%
9.5/17.7
2.0
/
6.5
/
26.5
/
39.0
strong buy
0.16
39.1↑
0.01
0.25
0.27
/
0.27
Price
Volume
Momentum
Market Cap
Financial Strength
Growth/Profitability
SMA 20
$10.42
2.69%
Current
0.11M
Bandwidth
7.990
Market Cap
195
Trailing P/E
N/A
Revenue Growth
-0.11
SMA 50
$11.00
7.83%
SMA 20
0.1M
8.98%
Lower
$10.01
Ent Value
407
Forward P/E
6.00
Earnings Growth
N/A
SMA 200
$11.89
14.73%
SMA 50
0.11M
4.63%
Upper
$10.84
Cash
21
PEG Ratio
0.61
Gross Margin
0.21
SMA 200
0.12M
-6.40%
Debt
233
Price/Sales
0.25
Operating Margin
0.03
Free CF
-23
Debt/Equity
92.04
Return on Assets
0.03
RS
3M : -0.26
6M : -0.12
9M : -0.22
12M : -0.40
Current Ratio
1.44
Return on Equity
-0.02
📝
📈
Finviz
Trading View
Yahoo
Google
Chat GPT
Quick Ratio
0.33
Beta
1.19
20
RAPP
Rapport Therapeutics, Inc
$26.53
8.9
/
-49.5%
24.4/52.5
10.3
/
36.0
/
34.8
/
0.2
strong buy
0.11
31.6↑
0.04
0.20
3.38
/
3.42
Price
Volume
Momentum
Market Cap
Financial Strength
Growth/Profitability
SMA 20
$30.39
12.70%
Current
0.41M
Bandwidth
32.360
Market Cap
1,323
Trailing P/E
N/A
Revenue Growth
N/A
SMA 50
$39.48
32.79%
SMA 20
0.9M
53.98%
Lower
$25.47
Ent Value
895
Forward P/E
-5.40
Earnings Growth
N/A
SMA 200
$35.74
25.77%
SMA 50
0.58M
29.21%
Upper
$35.31
Cash
436
PEG Ratio
N/A
Gross Margin
-1.09
SMA 200
0.41M
+0.95%
Debt
10
Price/Sales
66.14
Operating Margin
-7.68
Free CF
-56
Debt/Equity
2.39
Return on Assets
-0.26
RS
3M : -0.35
6M : -0.27
9M : -0.05
12M : 0.02
Current Ratio
15.72
Return on Equity
-0.40
📝
📈
Finviz
Trading View
Yahoo
Google
Chat GPT
Quick Ratio
15.35
Beta
1.22
Select Watchlist Portfolio
Add Stock